Following spinal cord injury (SCI), the population of mature oligodendrocytes undergoes substantial cell death; promoting their preservation and replacement is a viable strategy for preserving axonal integrity and white matter repair in the injured spinal cord. Dramatic upregulation of matrix chondroitin sulfate proteoglycans (CSPGs) is shown to pose an obstacle to endogenous repair processes, and targeting CSPGs improves functional recovery after SCI. However, the cellular and molecular mechanisms underlying the inhibitory effects of CSPGs remain largely unde- 
. Currently, the mechanisms by which oligodendrocyte differentiation, maturation, and survival are regulated in the microenvironment of SCI are not fully identified.
Following SCI, composition of the extracellular matrix (ECM) is altered profoundly by upregulation of chondroitin sulfate proteoglycans (CSPGs) (Cregg et al., 2014; .
CSPGs are shown to negatively influence several aspects of the secondary injury mechanisms including neuroinflammation, cell differentiation as well as axonal plasticity and regeneration (Alilain, Horn, Hu, Dick, & Silver, 2011; Barritt et al., 2006; Bradbury et al., 2002; Didangelos, Iberl, Vinsland, Bartus, & Bradbury, 2014; Dyck et al., 2018; Galtrey, Asher, Nothias, & Fawcett, 2007; Karimi-Abdolrezaee et al., 2010; Lang et al., 2015) . We previously uncovered a negative role for CSPGs in restricting the regenerative properties of adult NPCs in vitro and in cell transplantation approaches for SCI (KarimiAbdolrezaee et al., 2010) . Interestingly, our earlier genetic studies in primary cultures of spinal cord derived adult NPCs unraveled a novel inhibitory role for leukocyte common antigen-related (LAR) and protein tyrosine phosphatase-sigma (PTPσ) receptors in mediating the effects of CSPGs on the growth, proliferation, survival, and oligodendrocyte differentiation of NPCs . This in vitro evidence suggests that LAR and PTPσ signaling may play a determining role in regulating oligodendrocyte population in the injured adult spinal cord. To date, the impact of LAR and PTPσ on endogenous oligodendrogenesis and oligodendrocyte integrity in SCI has remained unexplored.
Our group and others have demonstrated that LAR and PTPσ can be efficiently manipulated in clinically relevant models of contusive and compressive SCI in the rat by two membrane permeable blocking peptides named intracellular LAR peptide (ILP) and intracellular sigma peptide (ISP), respectively (Dyck et al., 2018; Lang et al., 2015) . These studies have identified that modulation of PTPσ promotes axon regeneration and remarkable serotonergic reinnervation below the level of injury that is associated with some improvement in functional recovery in rats with SCI (Fisher et al., 2011; Lang et al., 2015) . Moreover, our recent studies uncovered that coinhibition of LAR and PTPσ with ILP and ISP following SCI fosters a pro-regenerative immune response characterized by an increase in the populations of M2 microglia/macrophages and regulatory T lymphocytes (Dyck et al., 2018) .
In the present study, utilizing ILP and ISP in complementary SCIrelevant in vitro and in vivo models, we have provided the first evidence that LAR and PTPσ receptors negatively influence oligodendrocyte integrity and replacement. We demonstrate that inhibition of LAR and PTPσ is sufficient to promote oligodendrogenesis as well as oligodendrocyte integrity, maturation, and myelination. Importantly, our in vitro findings uncover a new role for CSPGs in inducing caspase 3-mediated cell death in the populations of NPCs, OPCs, and mature oligodendrocytes, which can be overcome by the inhibition of LAR and PTPσ receptors. We show that CSPG-induced apoptosis in these populations appears to be mediated intracellularly through a Rho/R-OCK-dependent mechanism. We also demonstrate that modulation of CSPGs signaling augments the integrity of oligodendrocytes by attenuating their apoptosis following SCI. Altogether, our findings have unraveled new cellular and molecular mechanisms by which oligodendrocytes are regulated within the injured spinal cord. Moreover, our work identify LAR and PTPσ receptors as negative regulators of oligodendrocytes in SCI and provide new insights into the mechanisms by which CSPG signaling influences repair processes following SCI.
| MATERIALS AND METHODS

| Animals and animal care
All experimental protocols in this study were approved by the Animal Care Committee of the University of Manitoba in accordance with the guidelines and policies established by the Canadian Council of Animal Care. For in vivo studies, a total of 112 adult female Sprague Dawley (SD) rats (250 g), and for in vitro experiments, 20 C57BL/6 mice (8 weeks of age) were used for NPCs cultures, and 16 SD rat pups (1-3 days of age) were used for OPC cultures (provided by the Central Animal Care Facility at the University of Manitoba, Canada). For SCI, adult female rats were housed in standard plastic cages at 22 C before their injury and at 26 C afterward in a 12:12 h light/dark cycle.
Pelleted food and drinking water were available ad libitum.
| Isolation and culturing of spinal cord adult NPCs
Adult NPCs were isolated from the spinal cord of C57BL/6 mouse (8 weeks of age) as we described previously Dyck et al., 2018; Gauthier, Kosciuczyk, Tapley, & Karimi-Abdolrezaee, 2013) . Briefly, mice were deeply anesthetized by placing them in a bell jar saturated with a mixture of 40% isoflurane/60% propylene glycol.
Deep anesthesia was confirmed by lack of pedal reflexes. Mice were then killed by decapitation, and their spinal cords were excised under sterile conditions and transferred to an artificial cerebrospinal fluid (aCSF) solution (containing 124 mM NaCl, 3 mM KCl, 1 mM NaHPO 4 , 26 mM NaHCO 3 , 1.5 mM MgSO 4 , 1.5 mM CaCl 2 , and 10 mM glucose). Spinal cords were cleaned of meninges and nerve roots and were then subjected to a papain enzymatic solution (Worthington Biochemical Corporation, New Jersey, United States) for 50 min at 37 C.
The solution was then replaced by a papain inhibitor mixture, and cells were passed through a 70-μm cell strainer. Cellular components were isolated through a 7.5% BSA gradient and resuspended in serum-free medium (SFM, 100 ml) containing 84 ml of Dulbecco's Modified
Eagle's Medium-Ham's Nutrient Mixture F12 (DMEM/F12 Invitrogen ThermoFisher Scientific, Massachusetts, USA), 2 ml of 30% glucose, 1.5 ml of 7.5% NaHCO 3 , 0.5 ml of 1 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 10 mg of transferrin, 2.5 mg of insulin, 0.96 mg of putrescine, 1 μL of selenium, 1 μL of progesterone, 1% Lglutamine, 1% penicillin/streptomycin/neomycin (PSN), and growth factors: 1 μg of fibroblast growth factor-2 (FGF2; Fisher Scientific, ON, Canada, CB40060A), 2 μg of epidermal growth factor (EGF;
Sigma-Aldrich, Oakville, ON, Canada E-4127), and 200 μg of heparin (Sigma-Aldrich, Oakville, ON, Canada, H-3149). SFM plus growth factors will be referred to as "growth medium" in the text. Cells were plated onto uncoated tissue culture flasks (Biolite, Fisher Scientific ON, Canada). The neurospheres that were generated were passaged weekly by mechanical dissociation in growth medium.
| Plating spinal cord NPCs onto laminin and CSPGs substrates
This procedure was conducted as has been described previously . Briefly, tissue culture dishes were first coated with poly-D-lysine (PDL, 0.1 mg/ml, Sigma-Aldrich, Oakville, ON, Canada) overnight at room temperature, followed by laminin (5 μg/ml, SigmaAldrich, Oakville, ON, Canada, L2020), and/or a mixture of CSPGs 
| Primary culture of cortical and spinal cord OPCs
Primary OPCs cultures were isolated from the cerebral cortex and spinal cord of postnatal day 1-3 (P1-3) rats as we described previously ada, C3667-10UN) was added with laminin + CSPGs mixture during the coating step to degrade CSPGs as we described previously (Dyck et al., 2018) . After 24 hr of plating, culture medium was changed to OPC differentiation medium containing DMEM (Sigma-Aldrich, Oakville, ON, Canada), insulin (10 μg/ml), transferrin (50 μg/ml), sodium selenite (5.2 ng/ml), hydrocortisone (18 ng/ml), putrescine (16 μg/ml), progesterone (6.3 ng/ml), biotin (10 ng/ml), N-acetyl-L-cysteine and ISP (NH2-GRKKRRQRRRCDMAEHMERLKANDSLKLSQEYESI-NH2) peptides against LAR and PTPσ, respectively, were used as we described previously (Dyck et al., 2018; Lang et al., 2015) . Composition of the peptides was as follows: ILP and ISP bind to a highly conserved 24-amino acids intracellular wedge domain of LAR and PTPσ and block the catalytic activity of the receptor (Lang et al., 2015; Xie et al., 2006) . Efficacy of ILP and ISP in blocking CSPG effects has been verified and reported in vitro and in SCI (Dyck et al., 2018; Fisher et al., 2011; Lang et al., 2015; Xie et al., 2006 to block the Rho/ROCK pathway as we described previously Dyck et al., 2018) . One day after NPC or OPCs plating on laminin and/or CSPGs, cells were fixed with 3% paraformaldehyde (PFA). The slides were washed three times with phosphate-buffered saline (PBS) and incubated with the nuclear marker 4,6-diamidino-2-phenylindole (DAPI, 1:5,000 in PBS) for 15 min. Slides were coverslipped with Mowiol mounting medium. Assessment of cell attachment and spreading was performed as has been described previously . Briefly, using StereoInvestigator Cavalieri probe (MBF Bioscience, Williston, VT, USA), we performed unbiased measurement of the total area of cells and their processes in 8-10 separate bright field and fluorescent images (under 20× objective) containing an average of 300 cells for each treatment condition. To estimate the average growth area occupied by each NPC or OPC, the total area was divided by the total number of DAPI positive cells in each field as we reported previously . These experiments determined that a concentration of 10 μM was optimal for both ILP and ISP in NPCs, whereas 2.5 μM was found to be the optimal concentration for inhibiting LAR and PTPσ in OPCs (Supporting Information Figures S1 and S2). These concentrations were used for all in vitro experimental conditions thereafter.
| Assessment of NPC and OPC survival through MTT and LIVE/DEAD assays
These assessments were performed as we described previously . 
| MTT assay
| Assessment of oligodendrocyte morphological complexity by fractal dimension analysis
Fractal dimension (FD) analysis was performed to evaluate morphological complexity of oligodendrocytes as we described earlier . In this analysis, a numerical value close to 1 represents cells with low morphological complexity (essentially bipolar cells), whereas an FD value near 2 identifies those with high complexity (highly branched cells or with a bi-dimensional planar structure). FD was calculated using the Image J software (NIH, https://imagej.nih.
gov/ij/). Briefly, each image from O4+/MBP+ immunostained oligodendrocytes was converted to an 8-bit grayscale image, and then using the "Crop" tool, individual cell was cropped, and the "threshold"
was adjusted to select the whole cell. Next, the cell was outlined using the "Outline" tool. Then, in "Analyse," the "Tools" command was chosen. Next, the "Fractal box count" was selected, and the corresponding FD value was obtained. This procedure was performed for at least 50 cells per condition for each independent experiment (N = 4).
| In vitro assessment of myelination
The dorsal root ganglia (DRGs) were isolated from P1-3 SD rats as we described previously . The ganglia were digested with collagenase (0.06 μg/ml) for 1 hr at 37 C followed by additional half-media change every 3 days. After 14 days, DRGs were fixed with 4% PFA for 15 min followed by three washes with PBS. Then, fixed DRG cultures were coated with PDL (0.1 mg/ml), laminin (5 μg/ml), and/or CSPGs (10 μg/ml), and OPC were plated in these coated multichambers (20,000 cells/well). Cells were maintained in OPC differentiation medium for 10 days, and treatments were refreshed every 3 days along with half-media change.
| In vitro immunostaining, image processing, and analysis
For immunocytochemistry, NPC and OPC cultures were fixed with 3%
PFA for 20 min at room temperature and washed three times with PBS. Cells were incubated in a blocking solution containing 5% nonfat milk, 1% BSA, and 0.5% Triton X-100 in 0.1 M PBS for 1 hr. Cultures then underwent immunostaining procedures similar to methods described earlier for immunohistochemistry. List of all primary antibodies is provided in Table 2 .
For assessment of myelination, oligodendrocyte/DRG co-cultures were co-immunolabeled for myelin basic protein (anti-MBP, rabbit) and NF200 (anti-NF200, mouse) and were imaged from 5-7 different fields (20× objective) across the tissue culture well for each condition under the same microscopy settings as we described previously . 
| Rat model of compressive spinal cord injury
We used a clinically relevant clip-compression model of SCI that has been extensively characterized and used for SCI pathophysiology and therapeutics by our group and others (Dyck et al., 2018; Gauthier et al., 2013; Karimi-Abdolrezaee et al., 2010; Rivlin & Tator, 1977) . Under sterile conditions, general anesthesia was induced by inhalation of a mixture of O 2 (2 L/min) and isoflurane (4%) through a mask integrated into a surgical stereotaxic frame. After deep anesthesia was achieved, for maintenance, isoflurane was reduced to 2%. The surgical area was shaved and disinfected with 70% ethanol and povidone iodine. A midline incision was made at the thoracic area (T4-T9), and skin and superficial muscles were retracted. The rats received a T6-T8 laminectomy, and then, a 35 g aneurysm clip (University Health Network, Toronto, Ontario, Canada) was applied extradurally for 1 min at the level of T7 of the spinal cord to induce a compression injury. Animals also received 5 ml of 0.9% saline subcutaneously after SCI and thereafter as needed to prevent dehydration. In addition, animals received oral Clavamox ® (Amoxicillin plus Clavulanic acid, Pfizer, Mississauga, Ontario, Canada) in their drinking water starting 2 days before surgeries until 3 days post-operation to prevent trauma-induced hematuria and bladder infection. SCI rats were examined daily to monitor their recovery, and their bladders were expressed manually three times a day until the return of reflexive bladder control.
| Experimental groups and treatments
In rat SCI, we first performed a dosing study to determine the optimal daily dose of ILP and ISP treatment in promoting oligodendrogenesis.
We included three doses of 5 μg, 10 μg, and 15 μg per day for each Table 1 ). We delivered ILP and ISP simultaneously based on our earlier studies that showed a role for both LAR and PTPσ in regulating cell differentiation and inflammation in vitro and in SCI Dyck et al., 2018) . In our dosing studies, rats received ILP/ISP co-treatment at the time of SCI for either 7 days (N = 4 animals/ group) or 28 days (N = 5-6 animals/group) intrathecally in a sustained fashion using a mini-osmotic pump, and an indwelling intrathecal catheter inserted into the subarachnoid space surrounding the lesion site with the tip of the catheter located rostral to the lesion (Table 1) .
Once the optimal intrathecal dose was determined to be 10 μg/day of ILP and ISP, we conducted an extended time-point analysis at 1, 3, 
| In vivo BrdU incorporation studies
To examine the proliferation kinetics and fate of the mitotically active cells in the injured spinal cord after treatments, all rats received daily subcutaneous injection of BrdU (IP, 50 mg/kg) starting immediately following injury for up to 14 days post-injury as we described previously (Gauthier et al., 2013; Kataria et al., 2018) .
| Tissue processing
Tissue harvesting was performed at the end of the treatment period.
Animals that received treatment at the time of injury were euthanized at 1, 3, 5, 7, 14, and 28 days post-SCI (N = 4-6 animals/group/timepoint). SCI rats were deeply anesthetized with a mixture of 40% isoflurane/60% propylene glycol (Fisher Scientific, Pittsburgh, PA) 
| Immunohistochemistry on tissue sections
Frozen spinal cord cross-sections were air-dried at room temperature for 30 min. The injury epicenter for each sample was determined by Hematoxylin and Eosin staining, and the section near the midpoint of the lesion with the largest injury area was considered as the epicenter.
Slides were permeabilized with PBS for 5 min and then blocked in a solution containing 5% skim milk, 1% BSA, and 0.05% Triton-X in 0.1 M PBS for 1 hr at room temperature. This blocking solution was used for all immunostaining procedures unless mentioned otherwise.
Tissue sections were then incubated overnight at 4 C with primary antibodies (Table 2) were incubated with mouse anti-BrdU overnight and then appropriate secondary antibodies were added as described previously (Gauthier et al., 2013) . In a double immunostaining procedure, BrdU immunostaining and acid treatment were conducted after the first primary and antibodies was confirmed in several paradigms using a negative control, omitting the primary antibody in our immunostaining protocol, and a positive control, testing the antibody on tissues or cell preparations known to express the target antigen.
| Assessment of MBP immunodensity
For immunointensity measurement of MBP in the injured spinal cord tissue, immunostained sections were imaged using Zeiss AxioImager M2 fluorescence microscope (Zeiss) (N = 4-6 animals/group). Four images of the white matter (lateral funiculi, dorsal funiculus, and anterior funiculus) were acquired using a 20× objective. Immunodensity measurement was performed using NIH ImageJ software (imagej.nih. gov) as we described previously (Alizadeh et al., 2017; KarimiAbdolrezaee et al., 2010; Kataria et al., 2018) . Briefly, we traced the cross-sectional area of the spinal cord and measured the immunodensity of MBP in spinal cord cross-sections at 1, 2, and 3 mm rostral to the lesion center. After setting the threshold automatically, immunodensity above threshold was calculated. To account for variation in the size of spinal cord cross-sections, we used the following formula to calculate the percentage of MBP area: normalized immunodensity of tissue section X = total immunodensity of tissue section X/total area of the spinal cord section X.
| Assessment and analysis of endogenous cell response and oligodendrocyte cell death
Using confocal microscopy, we acquired images of immunostained sections of the spinal cord (Zeiss 710LSM) at 25× primary magnification.
For quantification of cell proliferation and differentiation, we examined two different cross-sections of the spinal cord within 1-3 mm rostral points to the injury center where all injured rats had an intact central canal and ependymal layer, region that endogenous NPCs reside (N = 4-7 rats/group). In each spinal cord cross-section, we first counted the number of BrdU-positive cells in six specified regions (368 mm × 368 mm) that included the ependymal/subependymal region, dorsal and lateral columns, and ventral gray and white matter. Then, we calculated the percentage of co-labeled BrdU+/Olig2+, BrdU+/APC+, or BrdU+/GFAP+ cells among all BrdU+ cells in each spinal cord section.
The same imaging techniques and analyses were performed for analysis of oligodendrocyte cell death by assessing the total number of APC +/cleaved caspase 3+ cells. All cell quantifications were executed in an unbiased manner by examiners blinded to the treatment groups based on the methods we described previously (Gauthier et al., 2013; KarimiAbdolrezaee et al., 2010; Kataria et al., 2018) .
| Western blotting in vitro and in vivo
For western blotting, spinal cord tissue or cultured cells were homogenized in Radioimmunoprecipitation assay buffer (RIPA The membranes were blocked with 5% nonfat milk in Tween-20
Tris-buffered saline (TTBS) and incubated overnight at 4 C with different antibodies (Table 2) 
| Statistical analysis
Using SigmaStat Software (4.0), we performed two-way repeated measures analysis of variance (ANOVA) followed by Holm-Sidak post hoc test for distance analysis in immunohistological assessment in SCI.
One-way ANOVA followed by Holm-Sidak post hoc was used in all immunocytochemistry and western blot analyses. Student's t-test was used when two groups were compared. The data was reported as means AE standard error of the mean (SEM). p ≤ .05 was considered statistically significant.
3 | RESULTS
| ILP and ISP efficiently block the inhibitory effects of CSPGs on NPCs
We previously reported that exposure of primary adult spinal cord
NPCs to a CSPG containing substrate impedes several properties of NPCs including their attachment, growth, survival, proliferation, and oligodendrocyte differentiation by signaling through both LAR and PTPσ . NPCs highly express LAR and PTPσ, and genetic knockdown of both receptors was sufficient to reverse the inhibitory effects of CSPGs on NPCs to a level closer to the control condition . Here, we evaluated the efficacy of ILP and ISP in blocking LAR-and PTPσ-mediated effects of CSPGs on NPCs. We first determined the optimal concentration of ILP and ISP in blocking the effects of CSPG on NPCs using a cell attachment and spreading assay (Supporting Information Figure S1 ). Dissociated NPCs were grown onto substrates containing either laminin or a combination of laminin and CSPGs (laminin + CSPG) for 1 day. Of note, laminin and CSPGs are highly upregulated in the ECM of the injured spinal cord, and therefore, their co-presence closely recapitulates the composition of the ECM in the injured spinal cord (Didangelos et al., 2016; . In addition, we used a relevant CSPG substrate containing a mixture of neurocan, phosphacan, versican, and aggrecan that are all present in the ECM of the injured spinal cord. Our stereology-based measurement of the total occupied area of NPC cell bodies and processes showed a significant 36.5%
decrease in the ability of NPCs to grow their processes on CSPG substrate, which was significantly overcome by both ILP and ISP treatment in a concentration dependent manner (Supporting Information Figure S1A 
| ILP/ISP mitigate CSPG-induced cell death in NPCs
We previously showed that CSPGs limit the survival of NPCs both in vitro Following SCI, oligodendrocytes are subject to degeneration and their replacement is vital for axon remyelination. We previously demonstrated that CSPGs drive the fate of NPCs toward an astrocytic fate by signaling through both LAR and PTPσ while limiting their potential for oligodendrocyte differentiation . Here, ILP and ISP treatment entirely blocked the effect of CSPGs on promoting astrocyte differentiation of NPCs (Figure 3a-n) . CSPGs caused a significant 17% increase in astrocyte differentiation (GFAP+/DAPI+) accompanied by a 37% decrease in oligodendrogenesis (Olig2+/DAPI+).
In addition, solitary treatment with ILP or ISP improved oligodendrocyte differentiation by NPCs, but once again, their co-treatment was more The data show the mean AE SEM. * p < .05, one-way ANOVA 
| ILP/ISP attenuate CSPG-induced dephosphorylation of Erk1/2 and Protein kinase B (AKT) in NPCs
We also examined the potential of ILP and ISP to modulate downstream intracellular pathways involved in CSPG signaling. Our previous work identified that CSPGs mediate their effects on NPCs by dephosphorylation of Erk1/2 and Akt pathways downstream of both LAR and PTPσ . Here, we studied phosphorylation of Erk1/2 and Akt in NPCs under ILP/ISP treatment as a proof-ofprinciple for their efficacy in attenuating LAR and PTPσ signaling activity. As anticipated, we found a significant 64% and 76% decrease in phosphorylation of both Erk1/2 (Supporting Information Figure S3A ) and Akt (Supporting Information Figure S3B ), respectively, in NPCs when exposed to a CSPGs substrate. Similar to our previous genetic studies , we found that although dephos- CSPG effects on OPCs maturation. Furthermore, we determined whether exposure to CSPGs affects the morphological complexity of oligodendrocytes. To address this, we used FD analysis, which assesses cellular branches. Our FD quantification showed no significant changes in morphological complexity of oligodendrocytes when grew on a CSPG substrate compared with laminin control condition.
We also found no apparent change in oligodendrocyte complexity under ILP, ISP, ILP + ISP, IMP, TAT, Y2732, and ChABC treatments (Supporting Information Figure S5 ).
Finally, we examined whether CSPGs affect the ability of oligodendrocytes to myelinate axons in vitro. OPCs were grown onto fixed DRG cultures coated with laminin or laminin + CSPGs substrate and Figure S6 ).
| ILP and ISP promote endogenous cell proliferation and oligodendrogenesis after SCI
Given our in vitro findings, we next utilized ILP and ISP to determine the role of LAR and PTPσ in oligodendrogenesis in a clinically relevant model of compressive/contusive SCI in the rat. We co-delivered ILP/ISP as our in vitro studies determined the involvement of both receptors in regulation of OPCs and NPCs in a cooperative manner, and that ILP/ISP co-treatment had greater effects than their solitary administration. We delivered TAT-conjugated ILP and ISP peptides intrathecally to the area of SCI in a sustainable fashion using an Alzet osmotic pump. In our previous SCI work, we confirmed the ability of TAT-conjugated ILP and ISP peptides to enter the spinal cord tissue successfully (Lang et al., 2015) . Here, we first conducted a dosing study to identify an effective intrathecal concentration for ILP/ISP in SCI. We began infusion of ILP/ISP intrathecally at the time of SCI at three concentrations of 5 μg, 10 μg, and 15 μg per day for duration of either 7 days (N = 4 animals/group) or 28 days post-SCI (N = 5-6 animals/group), representing subacute and early chronic phases of SCI, respectively (Table 1) . Of note, functional stability of ILP and ISP in
Alzet osmotic pumps at 37 C was verified using our in vitro attachment assay that confirmed the potency of ILP and ISP for up to 42 days (Supporting Information Figure S7 ). At the end of 7-day and 28-day treatment strategy, we studied the outcomes of ILP/ISP treatment on endogenous cell proliferation and differentiation in the injured spinal cord. We labeled proliferating cells in the injured spinal cord during the treatment period through BrdU pulsing starting at the time of SCI (Figure 7a-e) . We performed phenotypic analysis of BrdU-labeled cells in six specific regions in spinal cord cross-sections 3.4 | Inhibition of LAR and PTPσ confers protection to mature oligodendrocytes by attenuating caspase 3-mediated apoptosis following SCI After SCI, mature oligodendrocytes undergo significant loss in their population because of their susceptibility to apoptosis (Beattie, 2004; Casha, Yu, & Fehlings, 2001b; Robins-Steele, Nguyen, & Fehlings, 2012 we assessed RhoA activity by examining the amount of GTP-bound Rho (Kanazawa et al., 2013) . At 3 days post-SCI, we observed a significant 10.6-fold increase in RhoA activity, which was significantly blocked by 10 μg/day ILP/ISP treatment (Fig. 10j, N Our previous genetic studies unraveled that CSPGs directly impede several key regenerative properties of adult NPCs including their FIGURE 10 Inhibition of LAR and PTPσ attenuates caspase 3-mediated apoptosis in mature oligodendrocyte following SCI. (a) Preservation of mature APC+ oligodendrocytes was assessed at 7 days following injury when apoptosis is normally underway. There were a significantly higher number of APC+ oligodendrocytes under ILP and ISP treatment at 1 mm and 2 mm rostral points to the injury. (b-d) Immunodensity of MBP (a signature marker for myelin) at 28-day post-injury in the white matter regions at 1, 2, and 3 mm rostral to the injury site showed a significant increase in MBP expression in ILP/ISP treated SCI animals compared with SCI vehicle control. (e) Western blotting showed an overall reduction in cleaved caspase 3 expression at 1, 3, and 7 days post-injury under 10 μg/day of ILP and ISP, which was significantly different at 3 and 7 days post-injury compared with vehicle group. (f-i) Co-immunohistochemistry for APC and cleaved caspase 3 at 7 days post-SCI revealed a significant reduction in number of apoptotic oligodendrocytes at 2 mm rostral point to the injury in the spinal cord white matter of rats treated with ILP/ISP compared with the rats treated with vehicle. (j) Rho activity was assessed by G-LISA at 3 days post-SCI. We found a significant increase in Rho activity at 3 days post-injury which was significantly reduced by ILP and ISP treatment. N = 4-6 animals/group. The data show the mean AE SEM. Cleaved caspase 3 results have been normalized to the actin loading control before subsequent normalization to the SCI + vehicle values, *p < .05, two-way ANOVA (a, b, f ), one-way ANOVA (e, j) [Color figure can be viewed at wileyonlinelibrary.com] intrinsic capacity for oligodendrogenesis. Moreover, we identified the involvement of both LAR and PTPσ receptors in mediating CSPG inhibition of NPCs . In the present study, utilizing ILP and ISP, we have extended these initial discoveries to a clinically rele- NPCs and OPCs, and LAR and PTPσ appears to play a critical role in this mechanism. Therefore, the remarkable increase in endogenously generated oligodendrocytes that we observed following ILP and ISP treatment in SCI is likely attributed to modulation of both populations.
In agreement with our in vitro OPC data, CSPGs have previously been
shown to limit process outgrowth of OPCs and their myelination by signaling through PTPσ (Lau et al., 2012; Pendleton et al., 2013) .
Taken together, our new findings show that dysregulated activation of CSPGs and LAR/PTPσ axis in the injured spinal cord appears to be an underlying cause of inadequate oligodendrogenesis and remyelination.
In the present study, we have identified a previously unknown role for CSPG signaling in promoting apoptosis in NPC and oligodendrocyte populations. Oligodendrocytes are highly susceptible to delayed apoptosis following SCI that results in the loss of mature and new oligodendrocytes and subsequently demyelination Beattie, Farooqui, & Bresnahan, 2000; Casha et al., 2001b) . Our in vitro studies indicate that CSPGs directly induce cas- showed that corticospinal neurons in layer V of the sensorimotor cortex undergo progressive atrophy, with shrinkage of cell bodies but no evidence of cell death at 4 weeks post-injury (Carter et al., 2008) .
Interestingly, this cellular atrophy was overcome by ChABC treatment (Carter et al., 2008) , and it was later shown to also occur in rubrospinal neurons in a C5 lateral column SCI model (Carter et al., 2011) . In a transection model of SCI in lamprey, high expression of PTPσ in neurons was directly correlated with higher activity of caspase indicating a role for PTPσ in the retrograde neuronal degeneration (Zhang, Hu, Li, Huang, & Selzer, 2014) . In our studies, LAR and PTPσ were comparably important in mediating CSPG-induced cell death in NPCs and
OPCs and their co-inhibition remarkably attenuated apoptosis.
Although our in vitro experiments in the present study have identified a direct receptor-mediated mechanism for CSPG-induced cell death, our recent studies have also suggested an indirect involvement of CSPGs in apoptosis through their pro-inflammatory effects (Dyck et al., 2018) . We have demonstrated that CSPGs promote production of interleukin (IL)-1β and tumor necrosis factor-alpha (TNF-α) in activated microglia while suppressing IL-10 expression (Dyck et al., 2018) .
IL-1β and TNF-α are well known for their role in inducing cell death following SCI (Ferguson et al., 2008; Nesic et al., 2001 ). IL-10 has also been associated with repair and regeneration after CNS injury (David & Kroner, 2011; Puntambekar et al., 2015) . Thereby, the ability of ILP/ISP to reduce oligodendrocyte apoptosis can also be attributed to the positive immunomodulatory effects of inhibiting CSPG signaling (Dyck et al., 2018) . Taken together, our findings suggest that CSPGs contribute to cell death following SCI through LAR/PTPσ mediated mechanisms and promoting a pro-inflammatory response in immune cells (Dyck et al., 2018) .
Intracellularly, we identified that Rho activation is a putative mechanism by which CSPG signaling modulates cell death in NPCs, OPCs, and mature oligodendrocytes. Rho activation has been temporally correlated with induced cell death after SCI, which can be overcome by Rho antagonists (Dubreuil, Winton, & McKerracher, 2003; Eftekharpour, Nagakannan, Iqbal, & Chen, 2017) . Our new findings in vitro and in rat SCI indicate a role for LAR and PTPσ in regulating the Rho/ROCK pathway, and their co-inhibition with ILP/ISP significantly attenuates the SCI-induced increase in RhoA activity and caspase 3-mediated cell death. We and others previously showed activation of the Rho/ROCK pathway downstream to CSPGs signaling in NPCs and neurons (Dergham et al., 2002; Duffy et al., 2009; Monnier, Sierra, Schwab, Henke-Fahle, & Mueller, 2003) .
In NPCs, we found that ROCK inhibition allows NPCs to grow on CSPGs and promote their survival and oligodendrogenesis . Similarly, genetic knockdown approaches have implicated both LAR and PTPσ in mediating Rho activation in primary cerebellar granule neurons (Ohtake, Wong, Abdul-Muneer, Selzer, & Li, 2016) .
Notably, Rho activation has been associated with p75-mediated apoptosis in neurons and glial cells (Dubreuil et al., 2003) ; however, its link to LAR and PTPσ has not been reported previously. Taken together, our parallel in vitro and SCI studies suggest that Rho activation appears to be a plausible mechanism by which LAR and PTPσ mediate apoptosis in oligodendrocytes after SCI.
In conclusion, our work has uncovered a previously unknown role for CSPGs and LAR/PTPσ axis in regulating oligodendrogenesis, oligo- 
